Here’s what you should know:
1. Since the second quarter of fiscal year 2017, 249 investors have sold or reduced their equity in HCA, while only 197 started new or increased their positions in HCA.
2. Hedge funds still collectively hold 262.04 million shares of HCA.
3. HCA will report its next quarterly earnings Jan. 30. Analysts expect earnings of $1.87 per share, which is down 1.06 percent from last year’s $1.89 per share.
4. Despite the hedge fund reductions, 72 percent of market analysts are generally positive concerning HCA. Out of 29 analysts, 21 awarded HCA a buy rating, while seven issued a hold rating.
5. Analysts have issued targets between $74 and $105 per share. The consensus is at $89.66 per share.
More articles on transactions/valuations:
10 statistics on ASC shareholder equity
EmCare pays $33M to resolve alleged illegal remuneration & more — 6 ASC company key notes
Medical Facilities Corp. to pay $0.09 dividend — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
